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Kv1.3 activity is determined by raft association. In addition
to Kv1.3, leukocytes also express Kv1.5, and both channels
control physiological responses. Because the oligomeric com-
position may modify the channel targeting to the membrane,
we investigated heterotetrameric Kv1.3/Kv1.5 channel traffic
and targeting inHEK cells. Kv1.3 andKv1.5 generatemultiple
heterotetramers with differential surface expression accord-
ing to the subunit composition. FRET analysis and pharma-
cology confirm the presence of functional hybrid channels.
Raft association was evaluated by cholesterol depletion,
caveolae colocalization, and lateral diffusion at the cell sur-
face. Immunoprecipitation showed that both Kv1.3 and het-
eromeric channels associate with caveolar raft domains.
However, homomeric Kv1.3 channels showed higher associ-
ation with caveolin traffic. Moreover, FRAP analysis revealed
higher mobility for hybrid Kv1.3/Kv1.5 than Kv1.3 homotet-
ramers, suggesting that heteromers target to distinct surface
microdomains. Studieswith lipopolysaccharide-activatedmacro-
phages further supported that different physiologicalmechanisms
governKv1.3 andKv1.5 targeting to rafts.Our results implicate the
traffic and localization of Kv1.3/Kv1.5 heteromers in the complex
regulation of immune system cells.
The voltage-gated (Kv)4 Kv1.3 channel is involved in the
maintenance of the restingmembrane potential in immune sys-
tem cells. This protein plays a critical role during activation and
proliferation of leukocytes, and several studies point to this
channel as an excellent target for immunomodulation (1, 2).
Kv1.3 is abundantly expressed on so-called “T-effectormemory
cells.” These T-cells are key mediators in autoimmune inflam-
matory diseases. Kv1.3 blockers show more specificity for
autoreactive T-effector memory cells than any molecular
target expressed on all T-cells. In fact, Kv1.3 inhibitors ame-
liorate the symptoms of several T-cell-mediated diseases. In
addition to the level of Kv expression, the proper plasma
membrane localization and protein partnerships are critical
for the regulation of channel steady state properties (1, 2).
Therefore, the identification of the components of the chan-
nel complex and their regulation are essential for their pos-
sible use in pharmacology.
Kv channel expression in leukocytes is controlled post-trans-
lationally. Thus, Kv1.3 activity could be regulated by kinases,
modulatory  subunits, and assemblies of other Shaker (Kv1)
isoforms. Although considerable progress has beenmade in the
first two subjects, less is known about the heterotetrameric
structure of the functional channel (3–7). The Kv subunit com-
position determines the activity and the pharmacology of the
channel and affects surface expression andmembrane localiza-
tion (8, 9). Kv1.3 coassembles with Kv1.1, Kv1.2, and Kv1.4 in
the brain (10, 11) and forms heterotetrameric structures with
Kv1.5 in macrophages (12, 13). Hybrid channels express dis-
tinct biophysical and pharmacological properties, and the
Kv1.3/Kv1.5 ratio ismodulated by cytokines leading to different
phenotypes (12).
Recently, there has been interest in the channel targeting to
the membrane that defines the protein microenvironment.
Membrane microdomains rich in cholesterol and sphingolip-
ids, called lipid rafts, work as platforms on which signal trans-
duction pathways interface (14). Multiple Kv channels have
affinity for lipid rafts, and different isoforms target to distinct
lipid microdomains (15). In this context, Kv1.3 targets to raft
domains involved in immunological synapses in T-cells (16).
Furthermore, channel activity is regulated by the composition
of the lipid raft (17, 18).
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In this study, we focus on changes in traffic and targeting of
Kv1.3 by heteromultimeric association with Kv1.5. Both chan-
nels are present in mononuclear phagocytes, such as macro-
phages and dendritic cells (12, 13, 19–21). Activated macro-
phages are present in sites during inflammation. They produce
cytokines and act as antigen-presenting cells establishing
immunological synapseswithT-cells. Kv1.3 activity determines
the level of the macrophage activation, and this is conditioned
by the presence of Kv1.5 (12, 13, 19, 22). Kv1.3 and Kv1.5 coas-
semble as heteromultimeric complexes, and the oligomeric
stoichiometry compromises pharmacological responses (13).
Although therapies that selectively suppress T-effector mem-
ory cells without affecting other lymphoid subsets would have
immense value, the beneficial effects of Kv1.3 antagonists
might be in part due to their inhibitory action onmacrophages.
However, Kv channel redundancy may allow these cells to
escape the inhibitory effects of actual Kv1.3 blockers (13).
Therefore, a deeper understanding of the functional complex is
needed to warrant the development of more specific Kv1.3
blockers for autoimmune disease therapies.
Interestingly, both proteins have been located in raft
microdomains, and their functions can be influenced by lipid-
protein interactions (17, 23, 24). We report that functional
Kv1.3/Kv1.5 heterotetrameric channels exhibit different loca-
tion and targeting. In contrast to Kv1.5, Kv1.3 traffics efficiently
to the membrane, and the heterotetramer composition deter-
mines the subcellular distribution. We suggest that Kv1.3 and
the hybridKv1.3/Kv1.5 target to different lipid raft populations.
Our data have physiological relevance because experiments on
macrophages indicate that the expression of heteromeric
Kv1.5-containing channels impairs their localization in rafts.
However, LPS-induced activation, which selectively increases
the number of Kv1.3 subunits in the heterotetramer (12, 13, 19),
led to a relocalization of Kv1.3/Kv1.5 channels in lipid rafts. In
summary, the presence of Kv1.5 modifies the channel targeting
to raft membrane microdomains. Thus, different membrane
platform locations must be contemplated as an important reg-
ulatory mechanism of Kv1.3 in leukocyte physiology.
EXPERIMENTAL PROCEDURES
Expression Plasmids, Cell Culture, and Transient Trans-
fections—Rat Kv1.3 in pRcCMV was provided by T. C. Holmes
(New York University, New York, NY). Human Kv1.5 in pBK
was from Tamkun’s laboratory. Kv1.3 and Kv1.5 were sub-
cloned into pEYFP-C1 and pECFP-C1 (Clontech). The con-
structs were verified by sequencing. The Golgi (pECFP-Golgi)
and ER (pDsRed-ER) markers were obtained from Clontech.
HEK 293 cells were grown on gelatin-coated coverslips in
Dulbecco’s modified Eagle’s medium containing 10% fetal
bovine serum. Transient transfection was performed using
Lipofectamine 2000 (Invitrogen) at nearly 80% confluence.
Twenty-four hours after transfection, the cells were washed in
phosphate-buffered saline (PBS), fixed, and mounted with
Aqua Poly/Mount from Polysciences, Inc. Murine bone mar-
row-derived macrophages from 6–10-week-old BALB/c mice
(Charles River laboratories) were isolated and cultured as
described elsewhere (7, 12, 19). Briefly, the animals were killed
by cervical dislocation, and both femurswere dissectedwith the
adherent tissue removed. The ends of bones were cut off, and
the marrow tissue was flushed by irrigation with medium. The
marrow plugs were passed through a 25-gauge needle for dis-
persion. The cells were cultured in plastic dishes (150 mm) in
Dulbecco’s modified Eagle’s medium containing 20% fetal
bovine serum and 30% L-cell-conditioned media as a source of
macrophage-colony stimulating factor. Themacrophages were
obtained as a homogeneous population of adherent cells after 7
days culture and maintained at 37 °C in a humidified 5% CO2
atmosphere. Bone marrow-derived macrophages were cul-
tured in the absence or the presence of 100 ng/ml lipopolysac-
charide (LPS) for 24 h. All of the animal handling was approved
by the ethics committee of the University of Barcelona and was
in accordance with European Union regulations.
Because lipid rafts are sensitive to cholesterol-modifying
agents, in some experiments, transfected HEK cells were incu-
bated in the presence or the absence of 2%methyl--cyclodex-
trin (MCD) 1 h before raft isolation and confocal microscopy
experiments (23, 24).
Immunostaining—Anti-transferrin receptor polyclonal,
mouse anti-clathrin, and anti-caveolin polyclonal, which recog-
nizes caveolin isoforms 1, 2, and 3, were fromBDTransduction.
Antiserum against the S1-S2 epitope of Kv1.5 was generated in
the Philipson laboratory as previously described (25). Anti-
Kv1.3, anti-Kv1.3 external epitope, and anti-Kv1.5 polyclonal
antibodies were from Alomone. Alexa Fluor secondary anti-
bodies were fromMolecular Probes.
Transient transfected cells fixed with 4% paraformaldehyde
in PBS for 10 min were further permeabilized with 0.5%
CHAPS/PBS for 15min. After 30min of incubationwith block-
ing solution (10% goat serum, 5% nonfat dry milk, PBS), the
cells were reacted with anti-caveolin polyclonal (1:250) in 10%
goat serum, 0.5% CHAPS, PBS for 1 h. The cells were further
incubated 45minwithAlexa Fluor antibody (1:500) in PBS. The
experiments were performed at room temperature.
For antibody-induced patching experiments, gelatin-coated
coverslips with nonfixed cells were incubated with the S1-S2
Kv1.5 antiserum or anti-Kv1.3 external epitope antibody
(diluted 1:1000 and 1:200, respectively) inHEPES-based culture
medium for 1 h at room temperature. The cells were washed in
PBS and further incubated with Alexa 488 anti-rabbit (1:500).
The cells were fixed in methanol for 2 min and further stained
with anti-caveolin antibody. Alexa 594 anti-mousewas used for
caveolin visualization.
Raft Isolation and Immunoisolation of Caveolae—Low den-
sity, Triton-insoluble complexes were isolated as previously
described (23, 24, 26) from bonemarrow-derivedmacrophages
and HEK cells transient transfected with either Kv1.3-YFP or
double transfected Kv1.3-YFP/Kv1.5-CFP. The cells were
homogenized in 1 ml of 1% Triton X-100, and sucrose was
added to a final concentration of 40%. A 5–30% linear sucrose
gradient was layered on top and further centrifuged (39,000
rpm) for 20–22 h at 4 °C in a Beckman SW41 rotor. Gradient
fractions (1 ml) were collected from the top and analyzed by
Western blot. The relative expression was analyzed by using
Phoretix software, and statistics analysis was performed by Stu-
dent’s t test.
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Isolation of caveolae has been described previously (23). Fol-
lowing sucrose gradient sedimentation, floating membranes
were collected and pooled. The samples were dilutedwithMes-
buffered saline (25 mM Mes, pH 6.5, 0.15 M NaCl) containing
0.05% Triton X-100 and precleared with 25 l of protein
A-Sepharose beads for 2 h at 4 °Cwith gentlemixing. The beads
were then removed by centrifugation at 200  g for 2 min at
4 °C. The sample was then incubated overnight with anti-
caveolin polyclonal antibodies (5 ng/ml) at 4 °C with gentle
mixing. Twenty-five l of protein A-Sepharose was added to
each sample for 2 h at 4 °C. The beads were removed by centrif-
ugation at 200  g for 2 min at 4 °C, washed three times in PBS,
and resuspended in 50 l of SDS sample buffer.
Confocal Imaging: FRET and FRAP—Acceptor photo-
bleaching was used to measure the FRET. Fluorescent pro-
teins from fixed cells were excited with the 458 and 514-nm
lines using low excitation intensities and 475–495-nm band
pass and 530-nm long pass emission filters, respectively.
Subsequently YFP protein from half of the cell was bleached
by using maximum laser power obtaining 80% of acceptor
intensity bleaching. After photobleaching, images of the
donor and acceptor were taken. FRET efficiency was calcu-
lated as [(FCFPafter  FCFPbefore)/FCFPbefore]100, where
FCFPafter is the fluorescence of donor after bleaching, and
FCFPbefore is before bleaching. Loss of fluorescence caused by
scans was corrected measuring CFP intensity in the non-
bleached part of the cell. FRET values were expressed as the
means and standard error of n  15 cells for each group.
FRAP experiments were performed 1 day after transfection
at room temperature. The dishes were replaced every 2 h. Time
series were taken with one scan before bleaching, 30 itera-
tions of bleaching with 100% laser power of the 514-nm line,
followed by 4.5-s interval scans of the bleached region with
1–4% of laser power. In each cell, three different membrane
regions were bleached to reduce local variations. The experi-
ments were performed with n  15 cells/group. Fluorescence
intensity was normalized to the prebleach intensity. Any loss of
fluorescence during the recording was corrected with
unbleached regions of the cell. The values were fitted to a non-
linear regression equation, F(t)  M[1  exp(t/t1⁄2)], where F
is the fluorescence intensity,M is the mobile fraction, and t1⁄2 is
the time constant. The data are shown as the means  S.E.
Statistical analysis was performed by Student’s t test (GraphPad
PrismTM). The cells were examined with a 63 oil immersion
objective on a Zeiss LSM510 and a Leica TCS SL laser scanning
confocal microscope.
Electrophysiology—Whole cell currents weremeasured using
the patch clamp technique. An EPC-9 (HEKA) with the appro-
priate software was used for data recording and analysis. The
currents were filtered at 2.9 kHz. Series resistance compensa-
tion was always above 70%. Patch electrodes of 2–4 MOhms
were fabricated in a P-97 puller (Sutter Instruments Co.) from
borosilicate glass (outer diameter, 1.2mm; inner diameter, 0.94
mm; Clark Electromedical Instruments Co.). The electrodes
were filledwith the following solution 120mMKCl, 1mMCaCl2,
2 mM MgCl2, 10 mM HEPES, 11 mM EGTA, 20 mM D-glucose,
adjusted to pH 7.3 with KOH. The extracellular solution con-
tained 120mMNaCl, 5.4 mMKCl, 2 mMCaCl2, 1 mMMgCl2, 10
mM HEPES, 25 mM D-glucose, adjusted to pH 7.4 with NaOH.
After establishing the whole cell configuration of the patch
clamp technique, the cells were clamped to a holding potential
of 60 mV. To evoke voltage-gated currents, all of the cells
were stimulated with 200-ms square pulses ranging from 50
to50mV in 10-mV steps. All of the recordings were routinely
subtracted for leak currents. Conductance versus test potential
was calculated as previously described (12).
To block K currents, Margatoxin (Alomone) was added to
the external solution. Before the experiments, toxin was recon-
stituted to 10 M in Tris buffer (0.1% bovine serum albumin,
100 mM NaCl, 10 mM Tris, pH 7.5). All of the recordings were
made at room temperature (20–23 °C).
RESULTS
Kv1.3 and Kv1.5 Localize to Different Intracellular Com-
partments—Kv1.3-YFP andKv1.5-CFP constructs expressed in
HEK cells (Fig. 1, A and D) were functional (Fig. 1, B and E).
Although Kv1.3-YFP had good surface expression, Kv1.5-CFP
showed intracellular retention. This was not due to the fluores-
cence tagging. Immunostaining experimentswith cells express-
FIGURE 1. Kv1.3-YFP and Kv1.5-CFP have distinct cellular distribu-
tions. HEK cells were transient transfected with either wild type Kv1.3 (C)
and Kv1.5 (F) or Kv1.3-YFP (A and B) and Kv1.5-CFP (D and E). Representa-
tive traces of K currents from Kv1.3-YFP (B) and Kv1.5-CFP cells (E) are
shown. The cells were held at 60 mV, and currents were elicited by
depolarizing pulses in 10-mV steps (200 ms in duration) from 50 to 50
mV. C, immunolocalization of untagged Kv1.3. F, untagged Kv1.5. G–I,
Kv1.3-YFP cotransfected with Golgi-CFP marker. J–L, Kv1.5-CFP cotrans-
fected with DsRed-ER marker. I and L, merge panels show colocalization
(yellow). The bars represent 10 m.
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ing Kv1.3 and Kv1.5 wild type channels (Fig. 1,C and F) showed
similar patterns.
Channel distribution was studied intracellularly. Coex-
pression of Kv1.5-CFP with an ER marker showed that this
protein was mostly retained in this compartment (Fig. 1,
J–L). Although Kv1.3-YFP did not colocalize with ER (data
not shown), a Golgi signal was present in most of the intra-
cellular vesicles (Fig. 1, G–I). This intracellular distribution
was not a consequence of the presence of Golgi-CFP marker
because expression of Kv1.3 alone gave similar results (supple-
mentalMovie S1). Furthermore, liv-
ing cells revealed dynamic traffic of
Kv1.3 from the trans-Golgi network
to cell membrane (supplemental
Movie S2).
Kv1.3 and Kv1.5 Generate Func-
tional Heterotetramers with Dis-
tinct Surface Expression—Different
ratios of Kv1.3 and Kv1.5 generated
biophysically and pharmacologi-
cally distinct channels (Fig. 2, A and
B). K currents were evoked in cells
cotransfected with different ratios
of Kv1.3 and Kv1.5. Steady state
activation curves for Kv1.3, Kv1.5,
and Kv1.3/Kv1.5 indicate that
although increasing concentrations
of Kv1.5 did not modify k slope val-
ues (11 1, 7 1, 9 1, 11 1, and
10 1 for Kv1.3, Kv1.5, and 4:1, 1:1,
and 1:4 Kv1.3/Kv1.5 ratios, respec-
tively), half-activation voltages (V1⁄2)
shifted to depolarizing potentials
(15  1, 2  1, 14  1, 11  1,
and 10  1 for Kv1.3, Kv1.5, and
4:1, 1:1, and 1:4 Kv1.3/Kv1.5
ratios, respectively). Pharmacologi-
cal experiments demonstrated that,
unlike Kv1.5, Kv1.3, and hybrid
Kv1.3/Kv1.5 channels were sensi-
tive toMargatoxin. IC50 values were
0.3 0.02, 3 0.4, 25 8, and 58
17 nM for Kv1.3 and Kv1.3/Kv1.5
heteromers (4:1, 1:1, 1:4), respec-
tively. These results support the
idea that Kv1.5 coassembles with
Kv1.3, thus generatingmultiple het-
erotetrameric channels.
FRET also demonstrated that
Kv1.3 and Kv1.5 coassemble form-
ing heteromers (Fig. 2, C and D).
Although homotetrameric Kv1.3
channels, used as a positive control,
gave 17% FRET efficiency (Fig.
2D), cotransfection of YFPwithCFP
did not vary from 0% (data not
shown). Kv2.1 does not associate
with members of the Kv1 family
(27). However, cotransfection of Kv1.5 and Kv2.1 gave 5%
FRET efficiency. This energy transfer could be caused by the
fixation step because both subunits, which are processed in ER,
did not colocalize at the surface (data not shown). Low ratios of
Kv1.5 (4:1, 1:1) were significantly different from negative con-
trols, but FRET efficiencies were lower than those of Kv1.3. The
FRET efficiency of Kv1.3/Kv1.5 (ratio 1:4) was 5%. There
could be two reasons for this. First, the FRET efficiency was
measured by changes in the CFP signal (supplemental Fig. S1),
and the formation of Kv1.5-CFP homotetramers might mask
FIGURE 2. Kv1.3 associates with Kv1.5, leading to biophysically and pharmacologically distinct channels.
HEK cells were doubly transfected with different ratios of Kv1.3-YFP and Kv1.5-CFP. A, plot of normalized
conductance versus voltage of K currents from HEK cells expressing different channel ratios. The pulse pro-
tocols are shown in Fig. 1. The conductance was normalized to the peak current at 50 mV. B, inhibition of the
K current by Margatoxin. The currents were evoked at 50 mV from a holding potential of 60 mV during
a pulse potential of 200 ms. The percentage of inhibition was calculated by comparing the current at a
given concentration of toxin versus that obtained in its absence. The values are the means  S.E. The
symbols and color lines are: Kv1.3-YFP (black circles, black line), Kv1.5-CFP (closed triangle, blue line), and
the different Kv1.3-YFP/Kv1.5-CFP ratios 4:1 (white circles, yellow line), 1:1 (black squares, green line), and 1:4
(white squares, red line). C, representative FRET experiment. Panels show fluorescence signal of Kv1.3-YFP
and Kv1.5-CFP (ratio 1:1) before and after photobleaching of the YFP region bounded by the rectangle. The
FRET panel represents the difference of CFP fluorescence intensity after and before photobleaching.
D, histogram shows FRET efficiency of different ratios of Kv1.3-YFP and Kv1.5-CFP. Negative control was
performed with cells expressing Kv1.5-CFP and Kv2.1-YFP. Positive control was performed using cells
expressing Kv1.3-CFP and Kv1.3-YFP. *, p  0.05; **, p  0.01; ***, p  0.001 versus Kv2.1/Kv1.5 (Student’s
t test). E–M, HEK cells were doubly transfected with different ratios of Kv1.3-YFP (red) and Kv1.5-CFP
(green). The merge panels show colocalization (yellow). Kv1.3 and Kv1.5 colocalized in HEK cells with 4:1
(E–G), 1:1 (H–J), and 1:4 (K–M) ratios. The bars represent 10 m.
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the analysis. In fact, the highest ratio of Kv1.5 (1:4) resulted in
20% of current resistant to Margatoxin (see Fig. 2B). In addi-
tion, three donors and one acceptor in the complex might gen-
erate lower transfer efficiencies. Similar percentages were
obtained with reciprocal Kv1.3-CFP and Kv1.5-YFP construc-
tions (data not shown).
Kv1.3 traffic was influenced by the presence of Kv1.5. To
determine whether the composition of heteromeric complexes
governs the surface expression, different ratios of both subunits
were transfected (Fig. 2,E–M). Both channels colocalizedwhat-
ever the ratio used. However, increasing concentrations of
Kv1.5 modified the traffic, ranging from homomeric Kv1.3 to
resemble Kv1.5 channels. Although 4:1 (Fig. 2, E–G) and 1:1
(Fig. 2, H–J) Kv1.3/Kv1.5 ratios had surface expression, a 1:4
ratio presented high ER retention (Fig. 2,K–M) similar to Kv1.5
alone.
Kv1.3 and Kv1.5 Target to Lipid Rafts—Activation and apo-
ptosis involve a specific surface location of Kv1.3 (28). Changes
in this distribution, such as different lipid raft populations,
determine different spatial regulations affecting the function
(17, 18). AlthoughKv1.3 targets to lipid rafts, Kv1.5 localization
is uncertain (16, 23, 29, 30). Therefore we wanted to study
whether Kv1.3 and Kv1.3/Kv1.5 heteromers target to these
domains. We carried out lipid raft extractions from HEK cells
transfected with Kv1.3 (Fig. 3,A–C) and Kv1.3/Kv1.5 (ratio 1:1)
(Fig. 3, D–F). In both cases, floating fractions contained Kv1.3.
Kv1.5 was located in the same aliquots when cotransfectedwith
Kv1.3 (Fig. 3D). Immunoprecipitation under nonsolubilizing
conditions using Kv1.3 raft fractions (5 and 6) was performed
with anti-caveolin antibody. Kv1.3 and Kv1.5 immunoprecipi-
tated with caveolin in cells expressing Kv1.3 and Kv1.3/Kv1.5
(ratio 1:1) (Fig. 3, C, E, and F). Although Kv1.5 localized with
caveolin direct interaction between the two proteins is debata-
ble (23, 30). In this vein, we were unable to precipitate either
Kv1.3 orKv1.5 inHEKcells coexpressingKv1.3 andKv1.5 (ratio
1:4) (data not shown).
Lipid rafts are sensitive to cholesterol-modifying agents (23,
24, 26). Treatment of cells with 2%MCD shifted the buoyancy
of Kv1.3 and Kv1.5 containing rafts toward nonfloating frac-
tions (Fig. 4,A–D) without altering the channel expression pat-
tern (Fig. 4E). These results indicated that, in the absence of the
cholesterol-binding drug, channels targeted to cholesterol-rich
membrane domains. However, our data also suggested that the
heterotetramer mainly targeted to different raft population.
Thus, the heteromeric association modified the buoyancy of
the proteins (Fig. 4,A andB). AlthoughKv1.3 andKv1.5 located
in low buoyancy fractions by 64  5 and 19  1%, respectively,
their association shifted the floatability to 25  2 and 26  2%,
respectively. In this context, although membrane patching
experiments showed surface colocalization of Kv1.3 (Fig. 5,
A–C) and Kv1.5 (Fig. 5, D–F) with caveolin, the latter was par-
tial. This approach was unsuccessful with heterotetramers
because neither anti-Kv1.5 nor anti-Kv1.3 antibodies recog-
nized the complex.
Intracellular Kv1.3 distributed mostly in Golgi (see Fig. 1
and supplemental Movies S1 and S2), and caveolin-1 exhib-
ited similar distributions (data not shown). Hence, we ana-
lyzed the presence of caveolin in Kv1.3-related Golgi vesi-
cles. Caveolin was present in most of the Kv1.3 vesicles (Fig.
5, G–I). Kv1.3/Kv1.5 (ratio 1:1) channels also colocalized
with intracellular caveolin (Fig. 5, J–M). This distribution
was less robust than that observed for Kv1.3 and clearly defi-
cient with high Kv1.5 (1:4 Kv1.3/Kv1.5) ratios (Fig. 5, N–Q).
Kv1.5 alone produced similar results because channels were
retained in ER. High Kv1.5 ratios relocalized hybrid channels
out of caveolin vesicles. Therefore, a different composition
of the heterotetramer modified the association with the
caveolin traffic, which could impair the presence of channels
in raft domains.
Kv1.5Modifies Kv1.3Mobility at the Cell Surface—The com-
position of raft microdomains is crucial for Kv1.3 activity,
thereby modulating immune responses (17, 18, 28). To further
FIGURE 3. Kv1.3 and Kv1.3/Kv1.5 heterotetramers target to lipid rafts. Detergent-based isolation of lipid rafts. Sucrose density gradient centrifugation of
1% Triton X-100-solubilized extracts from cells, transfected with Kv1.3 alone (A–C) or doubly transfected with Kv1.3 and Kv1.5 (D–F), were analyzed by Western
blot. While caveolin indicates low buoyancy rafts, transferrin receptor (Transferrin-R) distributes in nonfloating fractions. B and C, fractions 5 and 6 from A were
immunoprecipitated (IP) with anti-caveolin antibody, and blots were immunoblotted (W) against caveolin (B) and Kv1.3 (C). E and F, fractions 5 and 6 from D
were immunoprecipitated (IP) with anti-caveolin antibody, and blots were immunoblotted (W) against Kv1.3 (E) and Kv1.5 (F). HEK, membrane extracts from
nontransfected HEK cells; SG, sucrose fractions number 5 and 6 as starting material; IPS, immunoprecipitated supernatant; , immunoprecipitation in the
absence of anti-caveolin antibody; , immunoprecipitation in the presence of anti-caveolin antibody.
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investigate whether Kv1.3 homo- and Kv1.3/Kv1.5 heterotet-
ramers target to different raft domains, we performed FRAP
experiments (Fig. 6). Fluorescence recovery within mem-
brane regions was monitored until a steady state was
achieved (supplemental Movie S3). Mobile fractions were
similar (55  1 and 57  1% for Kv1.3 and Kv1.3/Kv1.5 (1:1)
respectively), but the time constant (t1⁄2) of the heteromer
exhibited higher lateral mobility (45.7  1.4 s and 33.2 
1.3 s for Kv1.3 and Kv1.3/Kv1.5 (1:1), respectively, p 
0.001). These results were not a consequence of a turnover
from the trans-Golgi network (supplemental Movie S4).
Such experiments were not possible with Kv1.5 and Kv1.3/
Kv1.5 (ratio 1:4), because, as
shown in Figs. 1 and 2, channels
were mostly ER-retained. Our
results indicate that Kv1.5 targets
Kv1.3 to different raft populations
with higher mobility.
Activation of Macrophages Relo-
calizes Kv1.5 in Lipid Rafts—The
localization of Kv1.5 in lipid rafts is
under debate, and the association
with caveolin is one of the main
issues (23, 24, 30). We have demon-
strated that Kv1.5 associates with
Kv1.3 generating multiple func-
tional channels that target to dis-
tinct raft microdomains. This is
important in leukocytes where
Kv1.3 and rafts concentrate at the
immunological synapse, and raft
composition regulates Kv1.3-re-
lated cellular functions (16–18,
28). Unlike T-lymphocytes, macro-
phages express Kv1.3 and Kv1.5
channels (7, 12, 13, 19). Raft extrac-
tions showed that, although Kv1.3
colocalized partially with caveolin
(12  2%), Kv1.5 did not target to
lipid rafts (Fig. 7). Therefore, unlike
Kv1.3 homomers, Kv1.3/Kv1.5
hybrid channels localize in non-
floating fractions. Macrophage acti-
vation selectively induced Kv1.3,
which increases the Kv1.3/Kv1.5
ratio in the heteromeric channel
(12, 13, 19), and also augmented
caveolin in the same fractions. Rafts
extractions from LPS-activated
macrophages showed that more
Kv1.3 colocalized with caveolin and
Kv1.5 appeared in low buoyant den-
sity fractions (40  3 and 10  1%
for Kv1.3 and Kv1.5, respectively).
Our results indicate that different
physiological mechanisms govern
Kv1.3 and Kv1.5 locations in rafts,
which lead to different spatial regu-
lation of Kv1.3/Kv1.5 heterotetramers.
DISCUSSION
Traffic and subcellular localization regulate ion channel
activities which are essential to understanding their role (15,
31). Kv channels are either homo- or heterotetramers, and dif-
ferent structures modulate surface expression leading to
another mechanism regulating channel activity. This has been
suggested for neurons, where Kv1.1, Kv1.2, and Kv1.4 hetero-
meric channels show different traffic and surface expression
(8). Immune system cells express a unique subset of Kv chan-
nels, with Kv1.3 being the major isoform (1, 2). Kv control rest-
FIGURE 4. Cholesterol depletion impairs Kv1.3, Kv1.5, and Kv1.3/Kv1.5 localization in lipid rafts. HEK cells
were treated with or without 2% MCD 1 h before lipid raft extraction (A–D) and confocal microscopy studies
(E). A and C, cells were transfected with Kv1.3, Kv1.5, and Kv1.3/Kv1.5 (ratio 1:1) and fractions immunoblotted
(WB) against the channels. B and D, quantification of data from A and C. Relative abundance (%) of the protein
expression located in floating (white bar) and nonfloating (black bar, Kv1.3; gray bar, Kv1.5) fractions. 100%
represents the overall protein expression in all fractions. The values are the means  S.E. of four independent
experiments. *, p  0.05; **, p  0.01 (Student’s t test). A and B, cells incubated without MCD (MCD). C and
D, cells incubated with MCD (MCD). E, MCD did not alter Kv1.3, Kv1.5, and Kv1.3/Kv1.5 expression pat-
terns. The cells were transfected as described above and incubated in the absence (top panels, MCD) or the
presence (bottom panels, MCD) of MCD. HEK cells were transfected with Kv1.3-YFP (red), Kv1.5-CFP (green),
and both (Kv1.3/Kv1.5). The merge panels show colocalization (yellow) in doubly transfected cells. The bars
represent 10 m.
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ingmembrane potential and are involved in activation and pro-
liferation. Kv1.3 localizes in the immunological synapse and
targets to different raft domains upon activation and apoptosis
in T-cells (16, 28). In addition to Kv1.3, Kv1.5 is also expressed
in themyeloid lineage (19–21) and exerts important physiolog-
ical and pharmacological consequences in macrophages (13,
20, 22). Here we studied whether the association of Kv1.3 and
Kv1.5 influences traffic and targeting. These determinants
affect the expression and functional properties of the channels
and contribute to the diversity of K channels in leukocytes.
Kv1.3 has good surface expression. However, Kv1.5 shows
less robustmembrane localization, being retained in ER (23, 32,
33). Differential surface location and traffic have been
described for several Kv1 channels. Although Kv1.4 shows
strong plasma membrane expression, Kv1.1 and Kv1.2 are
retained in ER (8, 9). Folding and assembly efficiencies, con-
trolled by chaperon-like proteins such as calnexin or  sub-
units, could determine this variation (31, 34). In addition, sev-
eral ER retention signals within the pore andC- andN-terminal
domains determine traffic and surface expression (29).
Although VXXSL in the C terminus is considered a strong ER
export motif, neither Kv1.3 nor Kv1.5 shares this element. In
contrast, Kv1.3 and Kv1.5 possess basic intracellular motifs
(RXR and RR) near the T1 tetramerization domain that serve as
ER retention signals (35). Positive and negative determinants
have also been reported within the pore (31, 36). An external
FIGURE 5. Kv1.3 and Kv1.5 colocalize with caveolae in HEK cells. A and D,
cells expressing Kv1.3 and Kv1.5 patched with their respective antibody
against external epitope. B and E, caveolin. C and F, merge panels showed
colocalization (yellow). G–I, intracellular Kv1.3 traffics with caveolin. G, Kv1.3-
YFP; H, caveolin; I, colocalization (yellow). Hybrid Kv1.3/Kv1.5 channels (ratio
4:1, J–M) but not ratio 1:4 (N–Q) colocalized with intracellular caveolin. J and
N, Kv1.3-YFP. K and O, Kv1.5-CFP. L and P, Caveolin. M and Q, colocalization
between Kv1.3 and Kv1.5 (pink) or triple colocalization with caveolin (white).
The bars represent 10 m.
FIGURE 6. FRAP of Kv1.3 and heterotetramer Kv1.3/Kv1.5. FRAP experi-
ments monitored YFP intensity after bleaching for 150 s. Representative
images of Kv1.3-YFP at different times are shown. The arrows indicate regions
of analysis. The bar represents 10 m. The graph represents the regression
analysis of data from Kv1.3 and heterotetramer Kv1.3/Kv1.5.
FIGURE 7. Activation of macrophages targets Kv1.5 back to lipid rafts.
Detergent-based isolation of lipid rafts from bone marrow derived macro-
phages cultured in the absence (A) or the presence (B) of 100 ng/ml LPS.
Sucrose density gradient fractions were analyzed by Western blot. Although
caveolin localized low buoyancy raft fractions, clathrin marked nonfloating
fractions. LPS increased the relative abundance of Kv1.3 (12  2 and 40  3%,
for control and LPS-treated cells, respectively; p  0.01, Student’s t test) and
shifted Kv1.5 to low buoyancy rafts (10  1% in LPS-treated cells) in macro-
phages. The values are the means  S.E. of four independent experiments.
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proline in the pore, which is involved in Kv1.4-mediated ER
export (Pro505), is present inKv1.3 (Pro374) but is not conserved
in Kv1.5 (Gln453). Many underlying mechanisms must be
involved in Kv location. Although KChIP2 (Kv channel inter-
acting protein 2) enhances themembrane surface expression of
Kv4.2, it reduces Kv1.5 forward trafficking from the ER (37).
Our results implicate other elements, which need further
research.
Kv1.3 coassembles with Kv1.5 forming functional heterotet-
rameric complexes, and the stoichiometry determines the traf-
fic. Increasing concentrations of Kv1.5 impair Kv1.3 surface
expression and modulate Kv activity. Thus, the heterotetramer
activity results from amixture of characteristics of the isoforms
that comprise the channel. Consequently, differential expres-
sion of Kv1.3 and Kv1.5 changes the number of channels at the
surface, modifying the membrane excitability and signaling.
Lipid raft sublocalization regulates ion channels providing
compartmentalization where signal transduction pathways
converge. For instance, Kv1.3 targets to different rafts upon
activation and apoptosis in lymphocytes (16, 28). Disruption of
these domains alters channel activity, and raft association
seems to be dynamic (15, 17, 18, 29, 38). Scaffolding proteins
likemembrane-associated guanylate kinases are involved in the
K channel association with raft domains. This is the case of
PSD-95 for Kv1.4 or SAP97 for Kv1.5 (29, 38, 39). In addition,
Kv1.5 targets to caveolae without an apparent physical associ-
ation (23), but it formsmacromolecular complexes with SAP97
and caveolin-3 (29). Our results indicate that Kv1.5 localization
in caveolae could be partial and strongly dependent on scaffold-
ing and heterotetrameric associations. In fact, caveolin regu-
lates Kv1.5 trafficking to cholesterol-rich membrane microdo-
mains in thyroid cells but not in cardiomyocytes (24, 32).
Although, we found that Kv1.3 andKv1.5 localized in lipid rafts,
Kv1.5-containing channels in macrophages mistargeted these
domains. However, this may be counteracted by macrophage
activation, which accumulates caveolin and increases the
Kv1.3/Kv1.5 ratio (12, 13, 19). Similarly, Kv1.3 association shifts
more Kv1.5 protein to low buoyancy rafts in HEK cells. These
results indicate that different mechanisms govern Kv1.3 and
Kv1.5 targeting to rafts altering the traffic and localization of
hybrids.
In addition to Kv1.3 and Kv1.5, other Kv such as Kv1.4 and
Kv2.1 also target to distinct surface microdomains (26, 40).
Kv2.1 is retained within dynamic surface microdomains, but
neither distribution nor mobility changes following cholesterol
depletion (40, 41). Kv1.3 mobility is higher than for Kv1.4 and
Kv2.1, and it is further increased by cyclodextrin (40). Kv1.3/Kv1.5
heteromer lateral mobility is even higher than that of Kv1.3, indi-
cating thatKv1.5 changes the spatial regulation of Kv1.3.Macro-
phages do not express Kv1.5 homomeric channels (12, 13, 19),
demonstrating that, unlike Kv1.3, hybrids Kv1.3/Kv1.5 do not
colocalize in floating fractions. However, upon physiological
stimuli, which increases the Kv1.3/Kv1.5 ratio (12, 13), chan-
nels relocalized in rafts.
Towhat extent our results explain the role of Kv1.3 in the cell
signaling is not yet clear. Heteromeric structures, located in
distinct surface microdomains, may respond differentially
upon kinase activation. Kv1.3 andKv1.5 are regulated by signal-
ing molecules, such as PKC, PKA, and tyrosine kinases, which
are localized in caveolar and noncaveolar microdomains (4, 5,
42). In addition, kinases are tightly modulated by distinct raft
compositions (43, 44). PKA and PKC colocalize with caveolin-1
and cholesterol depletion regulates PKA and Kv1.3 (17, 44, 45).
Interestingly, tyrosine phosphorylation of Kv1.3 suppresses
currents and targeting of the channel to ceramide enriched
platforms (5, 18). In microglia, where Kv1.5 controls distinct
functions (20), transforming growth factor- enhances Kv1.3
independently of PKA, PKC, tyrosine kinases, and mitogen-
activated protein kinase extracellular signal-regulated kinase
(ERK) (46). It is tempting to speculate that this deactivation is a
consequence of a Kv1.3/Kv1.5 channel mistargeting to rafts in
brainmacrophages.Different phosphorylationmechanisms are
also mediated by distinct membrane surface locations.
Although PKA-mediated phosphorylation is related to the
caveolae pathway, G protein-coupled receptor kinases mediate
phosphorylation mainly in clathrin-coated pits (47). However,
although ligand-dependent phosphorylation and internaliza-
tion of epidermal growth factor receptor is via clathrin-coated
pits, some phosphorylation of epidermal growth factor recep-
tor localizes in caveolar lipid rafts (48, 49). This would agree
with epidermal growth factor-mediated inhibition of Kv1.3
currents (5). In this scenario, caveolae control the spatial and
temporal pattern of intracellular Ca2 signaling (50) in which
the localization of Kv1.3/Kv1.5 heteromeric channels plays a
pivotal role, fine tuning the cellular responses. In fact, LPS-
induced activation, which selectively accumulates more Kv1.3
in the Kv1.3/Kv1.5 channel (12, 13, 19), targets heterotetramers
back to rafts.
In summary, Kv1.3 traffic, targeting, and activity are dramat-
ically changed by the presence of Kv1.5. These two isoforms are
coexpressed in the myeloid lineage of the immune system and
play a crucial role in controlling the immunological response.
Therefore,ourresults further theunderstandingofhowvoltage-
dependent K channels are involved in leukocyte physiology
and open a new variable considering the use of Kv1.3 as a phar-
macological target.
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